speb/financial-data huggingface dataset:
Financial ratios for DAM.DE — quarterly report dated 2025-12-31
Total revenue: 61957647.05882353
Gross profit: 9084705.88235294
Operating income: -536470.5882352941
Net income: 2143529.411764706
Capital expenditures: 0
Operating cash flow: 5661176.470588235
Depreciation & amortization: 2487058.823529412
Net tangible assets: 163640000
Owner earnings: 4630588.2352941185
Return on net tangible assets (%): 2.8297410384344404
Buffett classification: The Gruesome
Stock price: 34.44705882352942
P/E ratio: 14.166658748627883
Shares outstanding: 3526182
Book value: 170754117.64705884
P/B ratio: 0.7113538487401906
Market cap (USD): 121466598.7764706
Debt to equity: 0.1067995948767061
Current ratio: 5.3442046602087
Quick ratio: 1.791524853199686
Interest coverage ratio: -4.071428571428571
COGS to revenue (%): 85.33723226492481
R&D to revenue (%): 2.079219200972201
SG&A to revenue (%): 13.53106486404375
Free cash flow (dilution-adjusted): 4575294.117647059
Buyback yield (%): 0
Retained earnings: 129505882.35294119
Inventory turnover: 0.4731334484355919
Receivables turnover: 2.020487243429887
Capitalized R&D asset: 3440623.529411765
ROCI (R&D-adjusted, %): -0.5494368923359751
Rosenberg metric: 0.6163655685441018
FCF margin (%): 7.384551116512229
Revenue growth (%): 1.0844737902838817
Rule of 40 score: 8.469024906796111
Financial ratios for DAM.DE — annual report dated 2025-12-31
Total revenue: 250444705.88235295
Gross profit: 36024705.88235294
Operating income: -5765882.352941177
Net income: -5383529.4117647065
Capital expenditures: 0
Operating cash flow: 211764.70588235295
Depreciation & amortization: 12680000
Net tangible assets: 163640000
Owner earnings: 7296470.5882352935
Buffett classification: The Gruesome
Stock price: 34.44705882352942
Shares outstanding: 3526182
Book value: 170754117.64705884
P/B ratio: 0.7113538487401906
Market cap (USD): 121466598.7764706
Debt to equity: 0.1067995948767061
Current ratio: 5.3442046602087
Quick ratio: 1.791524853199686
Interest coverage ratio: -3.9588045234248788
COGS to revenue (%): 85.61570476986819
R&D to revenue (%): 3.1511006304080267
SG&A to revenue (%): 13.555651593870666
Free cash flow (dilution-adjusted): -4383529.411764706
Buyback yield (%): 0
Retained earnings: 129505882.35294119
Inventory turnover: 1.9187371036341432
Receivables turnover: 8.167197391137542
Capitalized R&D asset: 14750518.87254902
ROCI (R&D-adjusted, %): -2.5060100354787314
Rosenberg metric: -1.2993875375520885
FCF margin (%): -1.7502982929189486
Revenue growth (%): 6.28577134630907
Rule of 40 score: 4.535473053390121
Financial ratios for DSS — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 4322000
Buffett classification: The Gruesome
Stock price: 12.48
Shares outstanding: 10042518
Market cap (USD): 125330624.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSS — annual report dated 2022-12-31
Total revenue: 28383000
Gross profit: -4609000
Operating income: -29978000
Net income: -59840000
Capital expenditures: 290000
Operating cash flow: -26953000
Depreciation & amortization: 12173000
Net tangible assets: 34484000
Owner earnings: -47957000
Return on net tangible assets (%): -139.0702934694351
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 10042518
Book value: 156681000
P/B ratio: 0.19549070978612593
Market cap (USD): 30629679.9
Debt to equity: 0.4178298581193636
Current ratio: 0.6513000759960916
Quick ratio: 0.5835414178699381
Interest coverage ratio: -237.9206349206349
COGS to revenue (%): 116.23859352429271
R&D to revenue (%): 4.4251840890673995
SG&A to revenue (%): 70.69724835288729
Free cash flow (dilution-adjusted): -29327000
Buyback yield (%): 0
Retained earnings: -194343000
Inventory turnover: 6.607650710995394
Receivables turnover: 1.6430101302460203
Capitalized R&D asset: 1256000
ROCI (R&D-adjusted, %): -16.511883108665803
FCF margin (%): -103.32593453827997
Rule of 40 score: -103.32593453827997
Financial ratios for DSS — annual report dated 2023-12-31
Total revenue: 25933000
Gross profit: 543000
Operating income: -23594000
Net income: -60627000
Capital expenditures: 570000
Operating cash flow: -19194000
Depreciation & amortization: 5206000
Net tangible assets: 16872000
Owner earnings: -55991000
Return on net tangible assets (%): -331.85751541014696
Buffett classification: The Gruesome
Stock price: 2.4
Shares outstanding: 10042518
Book value: 83214000
P/B ratio: 0.28963928185161153
Market cap (USD): 24102043.2
Debt to equity: 0.7550412190256447
Current ratio: 1.3420967451897141
Quick ratio: 1.2914044236648086
Interest coverage ratio: -42.66546112115732
COGS to revenue (%): 97.90614275247755
R&D to revenue (%): 6.497512821501562
SG&A to revenue (%): 46.18825434774226
Free cash flow (dilution-adjusted): -20012000
Buyback yield (%): 0
Retained earnings: -256176000
Inventory turnover: 9.006739978715856
Receivables turnover: 2.0314115619614603
Capitalized R&D asset: 2526520
ROCI (R&D-adjusted, %): -22.86452075540956
Rosenberg metric: 4.101910828025478
FCF margin (%): -77.16808699340608
Revenue growth (%): -8.631927562273193
Rule of 40 score: -85.80001455567927
Financial ratios for DSS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.27
Shares outstanding: 10042518
Market cap (USD): 12753997.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSS — annual report dated 2024-12-31
Total revenue: 19097000
Gross profit: -4442000
Operating income: -20930000
Net income: -46896000
Capital expenditures: 5476000
Operating cash flow: -8761000
Depreciation & amortization: 2984000
Net tangible assets: -718000
Owner earnings: -49388000
Buffett classification: The Gruesome
Stock price: 0.9
Shares outstanding: 10042518
Book value: 32716000
P/B ratio: 0.27626440273872116
Market cap (USD): 9038266.200000001
Debt to equity: 1.8062110282430615
Current ratio: 1.025635111029095
Quick ratio: 0.9880820569600788
Interest coverage ratio: -73.95759717314488
COGS to revenue (%): 123.26019793684873
R&D to revenue (%): 1.455726030266534
SG&A to revenue (%): 54.3017227836833
Free cash flow (dilution-adjusted): -8913000
Buyback yield (%): 0
Retained earnings: -303072000
Inventory turnover: 9.63923013923014
Receivables turnover: 5.2392318244170095
Capitalized R&D asset: 1821430
ROCI (R&D-adjusted, %): -50.23536046790452
Rosenberg metric: -2.9584569732937687
FCF margin (%): -46.67225218620726
Revenue growth (%): -26.360235992750546
Rule of 40 score: -73.0324881789578
Financial ratios for DSS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9
Shares outstanding: 10042518
Market cap (USD): 9038266.200000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DSS — quarterly report dated 2025-03-31
Total revenue: 4954000
Gross profit: -233000
Operating income: -3726000
Net income: -4777000
Capital expenditures: 52000
Operating cash flow: 168000
Depreciation & amortization: 523000
Net tangible assets: -2473000
Owner earnings: -4306000
Buffett classification: The Gruesome
Stock price: 0.87
Shares outstanding: 10042518
Book value: 29821000
P/B ratio: 0.29298114281881893
Market cap (USD): 8736990.66
Debt to equity: 1.8790449683109218
Current ratio: 0.9773164594434577
Quick ratio: 0.9310797809354647
Interest coverage ratio: -112.9090909090909
COGS to revenue (%): 104.70327008477997
SG&A to revenue (%): 70.5086798546629
Free cash flow (dilution-adjusted): 87000
Buyback yield (%): 0
Retained earnings: -307849000
Inventory turnover: 2.0756302521008405
Receivables turnover: 1.5642563940637828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.70641102456561
FCF margin (%): 1.7561566410981024
Rule of 40 score: 1.7561566410981024
Financial ratios for DSS — quarterly report dated 2025-06-30
Total revenue: 5285000
Gross profit: -214000
Operating income: -3425000
Net income: -2152000
Capital expenditures: 92000
Operating cash flow: 262000
Depreciation & amortization: 535000
Net tangible assets: -3740000
Owner earnings: -1709000
Buffett classification: The Gruesome
Stock price: 0.94
Shares outstanding: 10042518
Book value: 27378000
P/B ratio: 0.34480118781503394
Market cap (USD): 9439966.92
Debt to equity: 2.05844108408211
Current ratio: 0.3507764898201813
Quick ratio: 0.30353692970723734
Interest coverage ratio: -27.84552845528455
COGS to revenue (%): 104.0491958372753
SG&A to revenue (%): 60.75685903500473
Free cash flow (dilution-adjusted): 5000
Buyback yield (%): 0
Retained earnings: -310001000
Inventory turnover: 2.162406606370429
Receivables turnover: 1.7657868359505513
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.657516240742146
FCF margin (%): 0.0946073793755913
Revenue growth (%): 6.681469519580137
Rule of 40 score: 6.776076898955728
Financial ratios for DSS — quarterly report dated 2025-09-30
Total revenue: 6392000
Gross profit: 324000
Operating income: -3234000
Net income: -2229000
Capital expenditures: 82000
Operating cash flow: -8006000
Depreciation & amortization: 1087000
Net tangible assets: -4890000
Owner earnings: -1224000
Buffett classification: The Gruesome
Stock price: 1.35
Shares outstanding: 10042518
Book value: 26108000
P/B ratio: 0.5192814194882795
Market cap (USD): 13557399.3
Debt to equity: 2.1710203768959704
Current ratio: 0.3156068937520759
Quick ratio: 0.26263054950732556
Interest coverage ratio: -85.10526315789474
COGS to revenue (%): 94.93116395494367
SG&A to revenue (%): 55.66332916145181
Free cash flow (dilution-adjusted): -8089000
Buyback yield (%): 0
Retained earnings: -312256000
Inventory turnover: 2.113549285963079
Receivables turnover: 1.3910772578890098
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.526457328165783
FCF margin (%): -126.5488110137672
Revenue growth (%): 20.94607379375591
Rule of 40 score: -105.60273722001129
Financial ratios for DSS — annual report dated 2025-12-31
Total revenue: 20757000
Gross profit: -2169000
Operating income: -14434000
Net income: -23929000
Capital expenditures: 268000
Operating cash flow: -9129000
Depreciation & amortization: 3530000
Net tangible assets: -19635000
Owner earnings: -20667000
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 10042518
Book value: 8715000
P/B ratio: 1.0716628502581758
Market cap (USD): 9339541.74
Debt to equity: 4.94136546184739
Current ratio: 0.30202543372073437
Quick ratio: 0.25995873336702036
Interest coverage ratio: -54.26315789473684
COGS to revenue (%): 110.44948692007515
R&D to revenue (%): 1.638001638001638
SG&A to revenue (%): 49.058149058149056
Free cash flow (dilution-adjusted): -10470000
Buyback yield (%): 0
Retained earnings: -327001000
Inventory turnover: 11.474474474474475
Receivables turnover: 7.71635687732342
Capitalized R&D asset: 1082310
ROCI (R&D-adjusted, %): -70.04831031723549
Rosenberg metric: 8.176258992805755
FCF margin (%): -50.4408151466975
Revenue growth (%): 8.692464785044772
Rule of 40 score: -41.74835036165273
Financial ratios for DSS — quarterly report dated 2025-12-31
Total revenue: 4127000
Gross profit: -2046000
Operating income: -4050000
Net income: -14745000
Capital expenditures: 42000
Operating cash flow: -1553000
Depreciation & amortization: 1385000
Net tangible assets: -19635000
Owner earnings: -13402000
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 10042518
Book value: 8715000
P/B ratio: 1.0716628502581758
Market cap (USD): 9339541.74
Debt to equity: 4.94136546184739
Current ratio: 0.30202543372073437
Quick ratio: 0.25995873336702036
Interest coverage ratio: -56.25
COGS to revenue (%): 149.57596316937241
SG&A to revenue (%): -1.889992730797189
Free cash flow (dilution-adjusted): -2473000
Buyback yield (%): 0
Retained earnings: -327001000
Inventory turnover: 3.0895895895895897
Receivables turnover: 1.5342007434944238
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.11522797258369
FCF margin (%): -59.92246183668525
Revenue growth (%): -35.434918648310386
Rule of 40 score: -95.35738048499564
Financial ratios for EMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.89
Shares outstanding: 58130443
Market cap (USD): 458649195.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMD — annual report dated 2022-12-31
Total revenue: -148397560
Net income: -149608966
Capital expenditures: 0
Operating cash flow: 170856212
Net tangible assets: 616807549
Owner earnings: -149608966
Return on net tangible assets (%): -24.255372075545072
Buffett classification: The Gruesome
Stock price: 6.25
Shares outstanding: 58130443
Book value: 616807549
P/B ratio: 0.5890253278174453
Market cap (USD): 363315268.75
Debt to equity: 0.3809940400064721
Free cash flow (dilution-adjusted): 170856212
Buyback yield (%): 1.4245828472354838
Retained earnings: -399769203
Receivables turnover: -10.142861546501512
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMD — annual report dated 2023-12-31
Total revenue: 72556413
Net income: 71402426
Capital expenditures: 0
Operating cash flow: 50858053
Net tangible assets: 617562033
Owner earnings: 71402426
Return on net tangible assets (%): 11.561984413637035
Buffett classification: The Gruesome
Stock price: 7.02
P/E ratio: 5.71515188937698
Shares outstanding: 58130443
Book value: 617562033
P/B ratio: 0.6607849706654488
Market cap (USD): 408075709.85999995
Debt to equity: 0.4048176323041543
COGS to revenue (%): 0
SG&A to revenue (%): 0.9064326264309676
Free cash flow (dilution-adjusted): 50858053
Buyback yield (%): 3.8745246575505163
Retained earnings: -367005938
Receivables turnover: 4.514438829876261
Capitalized R&D asset: 0
FCF margin (%): 70.09449736717276
Rule of 40 score: 70.09449736717276
Financial ratios for EMD — annual report dated 2024-12-31
Total revenue: 62709882
Net income: 61548443
Capital expenditures: 0
Operating cash flow: 112291722
Net tangible assets: 616618400
Owner earnings: 61548443
Return on net tangible assets (%): 9.981609857895904
Buffett classification: The Gruesome
Stock price: 8.16
P/E ratio: 7.706846700898674
Shares outstanding: 58130443
Book value: 616618400
P/B ratio: 0.7692673700298273
Market cap (USD): 474344414.88
Debt to equity: 0.324349711263887
COGS to revenue (%): 0
SG&A to revenue (%): 1.5429992357504356
Free cash flow (dilution-adjusted): 112291722
Buyback yield (%): 0.6522387326480247
Retained earnings: -354842906
Receivables turnover: 4.276398233464369
Capitalized R&D asset: 0
FCF margin (%): 179.06543341924962
Revenue growth (%): -13.570862440512322
Rule of 40 score: 165.4945709787373
Financial ratios for EMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 616618400
Buffett classification: The Gruesome
Stock price: 8.16
Shares outstanding: 58130443
Book value: 616618400
P/B ratio: 0.7692673700298273
Market cap (USD): 474344414.88
Debt to equity: 0.324349711263887
Buyback yield (%): 0
Retained earnings: -354842906
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMD — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 622009442
Buffett classification: The Gruesome
Stock price: 9.02
Shares outstanding: 58130443
Book value: 622009442
P/B ratio: 0.8429720844334063
Market cap (USD): 524336595.85999995
Debt to equity: 0.37102316848752914
Buyback yield (%): 0
Retained earnings: -349451864
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXTX.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.984036488027366
Shares outstanding: 111544061
Market cap (USD): 221307487.04675028
Buyback yield (%): 0
Retained earnings: -13865324.204545453
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXTX.OL — annual report dated 2022-12-31
Total revenue: 0
Operating income: -4127000.809716599
Net income: -4059149.2914979756
Capital expenditures: 25403.13765182186
Operating cash flow: -3426309.91902834
Depreciation & amortization: 202728.13765182186
Net tangible assets: 6589886.1336032385
Owner earnings: -3881824.2914979756
Return on net tangible assets (%): -58.90578703179291
Buffett classification: The Gruesome
Stock price: 1.214574898785425
Shares outstanding: 111544061
Book value: 6589886.1336032385
P/B ratio: 20.558567151616753
Market cap (USD): 135478616.59919026
Debt to equity: 0.025890029769732863
Current ratio: 4.80810851555306
Quick ratio: 4.80810851555306
Interest coverage ratio: -412.17026696452945
Free cash flow (dilution-adjusted): -3411387.1457489873
Buyback yield (%): 0
Retained earnings: -4063069.63562753
Capitalized R&D asset: 2015367.3076923075
ROCI (R&D-adjusted, %): -31.86805363230139
Rule of 40 score: 0
Financial ratios for EXTX.OL — annual report dated 2023-12-31
Total revenue: 0
Operating income: -4752385.952848723
Net income: -4747906.581532417
Capital expenditures: 303809.33202357567
Operating cash flow: -4351198.330058939
Depreciation & amortization: 205489.58742632612
Net tangible assets: 4426536.542239686
Owner earnings: -4846226.3261296665
Return on net tangible assets (%): -109.48122261919997
Buffett classification: The Gruesome
Stock price: 1.1787819253438114
Shares outstanding: 111544061
Book value: 4426536.542239686
P/B ratio: 29.704063601770198
Market cap (USD): 131486122.98624755
Debt to equity: 0.02653664355325142
Current ratio: 3.609619493873779
Quick ratio: 3.609619493873779
Interest coverage ratio: -564.9476148770946
Free cash flow (dilution-adjusted): -5044030.746561886
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 3289152.382990781
ROCI (R&D-adjusted, %): -53.02778032195919
Rule of 40 score: 0
Financial ratios for EXTX.OL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -4665005.207413945
Net income: -4618870.344218888
Capital expenditures: 132855.25154457192
Operating cash flow: -7109221.094439541
Depreciation & amortization: 214677.22859664608
Net tangible assets: 10198270.344218887
Owner earnings: -4537048.367166813
Return on net tangible assets (%): -44.48841042676162
Buffett classification: The Gruesome
Stock price: 0.3315696649029982
Shares outstanding: 111544061
Book value: 10198270.344218887
P/B ratio: 3.6265587868687104
Market cap (USD): 36984626.92768959
Debt to equity: 0.0055970413895099795
Current ratio: 3.54283330524263
Quick ratio: 3.54283330524263
Interest coverage ratio: -970.5911010724254
Free cash flow (dilution-adjusted): -7490558.075904678
Buyback yield (%): 0
Capitalized R&D asset: 3598569.3544341247
ROCI (R&D-adjusted, %): -35.455925286478504
Rule of 40 score: 0
Financial ratios for EXTX.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 10198270.344218887
Buffett classification: The Gruesome
Stock price: 0.3315696649029982
Shares outstanding: 111544061
Book value: 10198270.344218887
P/B ratio: 3.6265587868687104
Market cap (USD): 36984626.92768959
Debt to equity: 0.0055970413895099795
Current ratio: 3.54283330524263
Quick ratio: 3.54283330524263
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GHCL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.356191480944218
Shares outstanding: 91664382
Market cap (USD): 582636363.9744165
Buyback yield (%): 0
Retained earnings: 368341025.97916394
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GHCL.NS — annual report dated 2023-03-31
Total revenue: 552919610.2314252
Gross profit: 245148599.26918393
Operating income: 171563946.40682095
Net income: 139046285.0182704
Capital expenditures: 42628501.827040195
Operating cash flow: 104282582.21680878
Depreciation & amortization: 16389768.57490865
Net tangible assets: 481601705.2375153
Owner earnings: 112807551.76613885
Return on net tangible assets (%): 23.423412031006965
Capex to operating income (%): 24.847004699902026
Buffett classification: The Great
Stock price: 5.540438489646773
P/E ratio: 3.652459108100248
Shares outstanding: 91664382
Book value: 481825822.1680877
P/B ratio: 1.0540341484340676
Market cap (USD): 507860870.1624848
Debt to equity: 0.09134964191729086
Current ratio: 4.689570151204586
Quick ratio: 3.542420461634436
Effective tax rate (%): 23.732057416267942
Interest coverage ratio: 40.91025268661051
COGS to revenue (%): 55.66288575538554
SG&A to revenue (%): 5.785917739295556
Free cash flow (dilution-adjusted): 59112058.46528624
Buyback yield (%): 0
Retained earnings: 461796589.5249696
Inventory turnover: 3.271658487952041
Receivables turnover: 20.78416739160295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.580552223579915
FCF margin (%): 10.690895633190658
Rule of 40 score: 10.690895633190658
Financial ratios for GHCL.NS — annual report dated 2024-03-31
Total revenue: 412061398.24919057
Gross profit: 163280968.94112003
Operating income: 89756565.5354359
Net income: 95203261.78198825
Capital expenditures: 12767717.95179278
Operating cash flow: 95578606.54754767
Depreciation & amortization: 12243674.301474998
Net tangible assets: 357041611.70404124
Owner earnings: 94679218.13167048
Return on net tangible assets (%): 26.517698505728216
Capex to operating income (%): 14.224828986746473
Buffett classification: The Great
Stock price: 4.970729366602687
P/E ratio: 4.785958242925352
Shares outstanding: 91664382
Book value: 357180717.1123636
P/B ratio: 1.2756535099725155
Market cap (USD): 455638835.4788868
Debt to equity: 0.07053143664827953
Current ratio: 4.2996737948532076
Quick ratio: 2.7264709435785908
Effective tax rate (%): 19.926169487422587
Interest coverage ratio: 31.304056879966538
COGS to revenue (%): 60.374602028997316
SG&A to revenue (%): 7.997543784085816
Free cash flow (dilution-adjusted): 82660990.526442
Buyback yield (%): 0
Retained earnings: 336796978.05492264
Inventory turnover: 3.1864162071666637
Receivables turnover: 19.107935272201523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.304668758623357
FCF margin (%): 20.060357722820104
Revenue growth (%): -25.47535109548352
Rule of 40 score: -5.414993372663417
Financial ratios for GHCL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 376576684.18537986
Buffett classification: The Gruesome
Stock price: 7.779861442904922
Shares outstanding: 91664382
Book value: 379048017.20019114
P/B ratio: 1.8813874729566806
Market cap (USD): 713136191.209508
Debt to equity: 0.05587085104572712
Current ratio: 4.634040210752575
Quick ratio: 3.3654617421164374
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GHCL.NS — quarterly report dated 2024-12-31
Total revenue: 90771651.70765823
Gross profit: 44964448.07087073
Operating income: 23555192.912926912
Net income: 19631658.70148036
Capital expenditures: 0
Depreciation & amortization: 3257955.4726658114
Owner earnings: 22889614.17414617
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.055251194777945
P/E ratio: 9.402919461008192
Shares outstanding: 91664382
Market cap (USD): 738379622.624082
Effective tax rate (%): 25.89431073172878
Interest coverage ratio: 57.73714285714286
COGS to revenue (%): 50.46421737957958
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GHCL.NS — quarterly report dated 2025-03-31
Total revenue: 91357259.76151508
Gross profit: 45173018.470890805
Operating income: 22201309.3289689
Net income: 17567220.014028523
Capital expenditures: 0
Depreciation & amortization: 3304886.602758943
Net tangible assets: 407762450.31564176
Owner earnings: 20872106.616787467
Return on net tangible assets (%): 5.118692660550459
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.853658536585366
P/E ratio: 8.940463740043045
Shares outstanding: 91664382
Book value: 407865326.1631985
P/B ratio: 1.5403034626771552
Market cap (USD): 628236374.1951219
Debt to equity: 0.03407970466166793
Current ratio: 5.306595316998967
Quick ratio: 3.6071059922855433
Effective tax rate (%): 28.15891380217048
Interest coverage ratio: 46.54656862745098
COGS to revenue (%): 50.553444150127326
Buyback yield (%): 0
Retained earnings: 387601122.2819733
Inventory turnover: 0.6314393031247504
Receivables turnover: 3.7257210965435044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.975047481825922
Revenue growth (%): 0.6451442083954534
Rule of 40 score: 0.6451442083954534
Financial ratios for GHCL.NS — annual report dated 2025-03-31
Total revenue: 371335047.93079257
Gross profit: 165824175.8241758
Operating income: 89731119.9438859
Net income: 72965863.92331073
Capital expenditures: 35292260.9305588
Operating cash flow: 74570960.95393968
Depreciation & amortization: 13039513.67781155
Net tangible assets: 407762450.31564176
Owner earnings: 50713116.670563474
Return on net tangible assets (%): 12.436926605504588
Capex to operating income (%): 39.33112720829642
Buffett classification: The Good
Stock price: 6.853658536585366
P/E ratio: 8.61000391711139
Shares outstanding: 91664382
Book value: 407865326.1631985
P/B ratio: 1.5403034626771552
Market cap (USD): 628236374.1951219
Debt to equity: 0.03407970466166793
Current ratio: 5.306595316998967
Quick ratio: 3.6071059922855433
Effective tax rate (%): 25.347159926800387
Interest coverage ratio: 48.64131812420786
COGS to revenue (%): 55.34378541745372
SG&A to revenue (%): 9.21798262183604
Free cash flow (dilution-adjusted): 37758943.184475094
Buyback yield (%): 0
Retained earnings: 387601122.2819733
Inventory turnover: 2.809781826900024
Receivables turnover: 15.14374255065554
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.107669133538543
FCF margin (%): 10.168429668807455
Revenue growth (%): -9.883563588203206
Rule of 40 score: 0.28486608060424956
Financial ratios for GHCL.NS — quarterly report dated 2025-06-30
Total revenue: 93127779.0779312
Gross profit: 42511116.31172479
Operating income: 19925111.16311725
Net income: 16862859.817458462
Capital expenditures: 0
Depreciation & amortization: 3148841.5633044704
Owner earnings: 20011701.38076293
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.854200795693893
P/E ratio: 11.621640315138112
Shares outstanding: 91664382
Market cap (USD): 628286080.041189
Effective tax rate (%): 25.93030427631579
Interest coverage ratio: 71.24686192468619
COGS to revenue (%): 54.351841381130086
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.9380171001603959
Rule of 40 score: 1.9380171001603959
Financial ratios for GHCL.NS — quarterly report dated 2025-12-31
Total revenue: 84275370.39099923
Gross profit: 35824885.81931603
Operating income: 14469199.06427537
Net income: 11809067.617244069
Capital expenditures: 0
Depreciation & amortization: 3205970.8143032193
Owner earnings: 15015038.431547288
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.125320262894063
P/E ratio: 8.52386253129923
Shares outstanding: 91664382
Market cap (USD): 561473696.4502618
Effective tax rate (%): 26.06360719765658
Interest coverage ratio: 49.20075757575757
COGS to revenue (%): 57.490681259417876
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -9.505658542038347
Rule of 40 score: -9.505658542038347
Financial ratios for GRINFRA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.921271264670978
Shares outstanding: 96760529
Market cap (USD): 1927592745.9220629
Buyback yield (%): 0
Retained earnings: 605507121.1921403
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRINFRA.NS — annual report dated 2023-03-31
Total revenue: 996329171.7417784
Gross profit: 253308708.89159563
Operating income: 130801717.4177832
Net income: 177153081.6077954
Capital expenditures: 32818416.565164436
Operating cash flow: -44271449.45188794
Depreciation & amortization: 29921023.142509136
Net tangible assets: 762882618.7576127
Owner earnings: 174255688.18514007
Return on net tangible assets (%): 22.841743133291327
Capex to operating income (%): 25.090203105163965
Buffett classification: The Good
Stock price: 12.051035322777102
P/E ratio: 6.582242556814134
Shares outstanding: 96760529
Book value: 763110060.9013399
P/B ratio: 1.5280424313267638
Market cap (USD): 1166064552.8295982
Debt to equity: 0.909280338411299
Current ratio: 2.622132158471414
Quick ratio: 2.218982337362678
Effective tax rate (%): 25.503215380557126
Interest coverage ratio: 2.5306225991499094
COGS to revenue (%): 74.57580124360281
SG&A to revenue (%): 0.4759040876298349
Free cash flow (dilution-adjusted): -80505322.7771011
Buyback yield (%): 0
Retained earnings: 734237028.0146164
Inventory turnover: 6.8983166844283135
Receivables turnover: 18.953342019269247
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.28405995951446
FCF margin (%): -8.08019327953251
Rule of 40 score: -8.08019327953251
Financial ratios for GRINFRA.NS — annual report dated 2024-03-31
Total revenue: 952519330.8550186
Gross profit: 236515037.77431348
Operating income: 114353915.33757046
Net income: 158729895.67094377
Capital expenditures: 11568149.658232402
Operating cash flow: -190719870.4880681
Depreciation & amortization: 29287708.358316343
Net tangible assets: 910254359.0358557
Owner earnings: 176449454.3710277
Return on net tangible assets (%): 19.38463162735343
Capex to operating income (%): 10.116094078705968
Buffett classification: The Great
Stock price: 15.45573416506718
P/E ratio: 9.42169720186512
Shares outstanding: 96760529
Book value: 911667765.9191749
P/B ratio: 1.6404057155486396
Market cap (USD): 1495505013.8952737
Debt to equity: 0.5020477027148345
Current ratio: 2.9661682470184885
Quick ratio: 2.56826827011019
Effective tax rate (%): 23.48169471252561
Interest coverage ratio: 1.761157972032673
COGS to revenue (%): 75.16952883654253
SG&A to revenue (%): 0.7773315335061038
Free cash flow (dilution-adjusted): -205977707.1591318
Buyback yield (%): 0
Retained earnings: 895715937.1627294
Inventory turnover: 7.777927903224146
Receivables turnover: 25.79989040892995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.659390046311705
FCF margin (%): -21.62451726562212
Revenue growth (%): -4.397125180041811
Rule of 40 score: -26.021642445663932
Financial ratios for GRINFRA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 948859340.6593406
Buffett classification: The Gruesome
Stock price: 19.91602962255136
Shares outstanding: 96760529
Book value: 950344493.5499283
P/B ratio: 2.0277757959740277
Market cap (USD): 1927085561.85774
Debt to equity: 0.5421570730487113
Current ratio: 3.026572380528975
Quick ratio: 2.6449366354730346
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GRINFRA.NS — annual report dated 2025-03-31
Total revenue: 770566904.3722235
Gross profit: 192263479.07411736
Operating income: 84460135.60907178
Net income: 118704150.10521393
Capital expenditures: 5933306.055646481
Operating cash flow: -238703448.6789806
Depreciation & amortization: 28592401.215805467
Net tangible assets: 992393722.2352115
Owner earnings: 141363245.2653729
Return on net tangible assets (%): 14.2446734696159
Capex to operating income (%): 7.024978130640356
Buffett classification: The Great
Stock price: 12.14015637764033
P/E ratio: 9.895929941809216
Shares outstanding: 96760529
Book value: 994061667.056348
P/B ratio: 1.1817053128320816
Market cap (USD): 1174687953.2432022
Debt to equity: 0.5845752603709884
Current ratio: 2.895614380876959
Quick ratio: 2.5790698180679974
Effective tax rate (%): 24.03071944378917
Interest coverage ratio: 1.6970834168205455
COGS to revenue (%): 75.0490868497975
SG&A to revenue (%): 0.987805482492242
Free cash flow (dilution-adjusted): -257376245.03156415
Buyback yield (%): 0
Retained earnings: 977509714.7533317
Inventory turnover: 9.194575342598153
Receivables turnover: 29.33199105902017
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.460990669658675
FCF margin (%): -33.40089531112774
Revenue growth (%): -19.102229276488018
Rule of 40 score: -52.50312458761576
Financial ratios for GRINFRA.NS — quarterly report dated 2025-03-31
Total revenue: 266024573.29904136
Gross profit: 91776981.52910918
Operating income: 57064472.76128127
Net income: 47217231.70446575
Capital expenditures: 0
Depreciation & amortization: 6682440.963292027
Net tangible assets: 992393722.2352115
Owner earnings: 53899672.66775777
Return on net tangible assets (%): 5.431279084107586
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.14015637764033
P/E ratio: 6.219593519351229
Shares outstanding: 96760529
Book value: 994061667.056348
P/B ratio: 1.1817053128320816
Market cap (USD): 1174687953.2432022
Debt to equity: 0.5845752603709884
Current ratio: 2.895614380876959
Quick ratio: 2.5790698180679974
Effective tax rate (%): 19.98709582924579
Interest coverage ratio: 4.046656011088875
COGS to revenue (%): 65.50056245144631
Buyback yield (%): 0
Retained earnings: 977509714.7533317
Inventory turnover: 2.770401385689621
Receivables turnover: 10.126350302890598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6896525333648276
Rule of 40 score: 0
Financial ratios for GRINFRA.NS — quarterly report dated 2025-06-30
Total revenue: 232598864.966066
Gross profit: 70465937.28059912
Operating income: 40466405.33582963
Net income: 28598911.77158905
Capital expenditures: 0
Depreciation & amortization: 6121589.047507606
Owner earnings: 34720500.819096655
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.388836882752168
P/E ratio: 13.016509241350368
Shares outstanding: 96760529
Market cap (USD): 1489031997.4698107
Effective tax rate (%): 23.892688966405906
Interest coverage ratio: 2.96270001867612
COGS to revenue (%): 69.7049522185418
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.56489500892879
Rule of 40 score: -12.56489500892879
Financial ratios for GRINFRA.NS — quarterly report dated 2025-09-30
Total revenue: 180624532.1307779
Gross profit: 71686674.18263811
Operating income: 37893844.41939121
Net income: 21715535.51296505
Capital expenditures: 0
Depreciation & amortization: 5740710.259301014
Net tangible assets: 1004238838.7824126
Owner earnings: 27456245.772266064
Return on net tangible assets (%): 2.7340354417635684
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.7325817361894
P/E ratio: 13.624002858384285
Shares outstanding: 96760529
Book value: 1008060450.9582863
P/B ratio: 1.318147013967528
Market cap (USD): 1328771873.3294249
Debt to equity: 0.625426256961335
Current ratio: 3.008733818241193
Quick ratio: 2.672502110733737
Effective tax rate (%): 27.201024300248395
Interest coverage ratio: 2.67605290667448
COGS to revenue (%): 60.31177308144683
Buyback yield (%): 0
Inventory turnover: 1.4709737015247737
Receivables turnover: 8.228624901901972
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.337843064644458
Revenue growth (%): -22.345050068438933
Rule of 40 score: -22.345050068438933
Financial ratios for GRINFRA.NS — quarterly report dated 2025-12-31
Total revenue: 257132315.91845828
Gross profit: 78336248.18981843
Operating income: 46682187.81330066
Net income: 28874167.31647544
Capital expenditures: 0
Depreciation & amortization: 5459162.303664922
Owner earnings: 34333329.62014036
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.096691545059597
P/E ratio: 8.494241171842981
Shares outstanding: 96760529
Market cap (USD): 1073721744.049794
Effective tax rate (%): 27.417779900940083
Interest coverage ratio: 2.732499758743274
COGS to revenue (%): 69.53465459601726
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 42.357360257291255
Rule of 40 score: 42.357360257291255
Financial ratios for HRL — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.32
Shares outstanding: 550314959
Market cap (USD): 19987439310.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HRL — annual report dated 2022-10-31
Total revenue: 12458806000
Gross profit: 2164686000
Operating income: 1285421000
Net income: 1000226000
Capital expenditures: 277694000
Operating cash flow: 1134977000
Depreciation & amortization: 235885000
Net tangible assets: 806428000
Owner earnings: 958417000
Return on net tangible assets (%): 118.84718784566013
Capex to operating income (%): 21.603350186436973
Buffett classification: The Great
Stock price: 40.72
P/E ratio: 22.40376188029505
Shares outstanding: 550314959
Book value: 7540220000
P/B ratio: 2.97190600943739
Market cap (USD): 22408825130.48
Debt to equity: 0.4375661452848856
Current ratio: 2.4687497030407273
Quick ratio: 1.3039505425361069
Effective tax rate (%): 21.74136200290587
Interest coverage ratio: 20.561801167719747
COGS to revenue (%): 82.62525317434111
SG&A to revenue (%): 7.0573777294549735
Free cash flow (dilution-adjusted): 831116000
Buyback yield (%): 0
Retained earnings: 7313374000
Inventory turnover: 5.998698179957682
Receivables turnover: 14.242379139659567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.862419237745097
FCF margin (%): 6.670912124323952
Rule of 40 score: 6.670912124323952
Financial ratios for HRL — annual report dated 2023-10-31
Total revenue: 12110010000
Gross profit: 1999841000
Operating income: 1057674000
Net income: 793572000
Capital expenditures: 264889000
Operating cash flow: 1047847000
Depreciation & amortization: 253311000
Net tangible assets: 1049251000
Owner earnings: 781994000
Return on net tangible assets (%): 74.52878291276348
Capex to operating income (%): 25.04448440634827
Buffett classification: The Good
Stock price: 29.35
P/E ratio: 20.35321816627855
Shares outstanding: 550314959
Book value: 7738985000
P/B ratio: 2.0870623275080646
Market cap (USD): 16151744046.650002
Debt to equity: 0.42760749633188333
Current ratio: 1.4262839479257505
Quick ratio: 0.6993943184806832
Effective tax rate (%): 21.762022039089388
Interest coverage ratio: 14.409334895506934
COGS to revenue (%): 83.48604997023124
SG&A to revenue (%): 7.780067894246165
Free cash flow (dilution-adjusted): 753559000
Buyback yield (%): 0.07617134078193705
Retained earnings: 7492952000
Inventory turnover: 6.016503749689063
Receivables turnover: 14.685332748022454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.496941545098876
FCF margin (%): 6.222612532937628
Revenue growth (%): -2.7995941184090998
Rule of 40 score: 3.4230184145285283
Financial ratios for HRL — annual report dated 2024-10-31
Total revenue: 11920797000
Gross profit: 2022138000
Operating income: 1016844000
Net income: 805038000
Capital expenditures: 255967000
Operating cash flow: 1266738000
Depreciation & amortization: 257756000
Net tangible assets: 1337229000
Owner earnings: 806827000
Return on net tangible assets (%): 60.33573905441776
Capex to operating income (%): 25.172691189602336
Buffett classification: The Good
Stock price: 28.54
P/E ratio: 19.509624303275125
Shares outstanding: 550314959
Book value: 8004010000
P/B ratio: 1.9622650308857683
Market cap (USD): 15705988929.859999
Debt to equity: 0.35716559574513274
Current ratio: 2.32007312232768
Quick ratio: 1.1935804999503323
Effective tax rate (%): 22.290459845823104
Interest coverage ratio: 12.570079363117166
COGS to revenue (%): 83.03688922812795
SG&A to revenue (%): 8.433110638491705
Free cash flow (dilution-adjusted): 987064000
Buyback yield (%): 0
Retained earnings: 7677537000
Inventory turnover: 6.279679629512149
Receivables turnover: 13.729081825385126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.448755050712771
FCF margin (%): 8.280184621883922
Revenue growth (%): -1.5624512283639733
Rule of 40 score: 6.717733393519949
Financial ratios for HRL — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.54
Shares outstanding: 550314959
Market cap (USD): 15705988929.859999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HRL — quarterly report dated 2025-01-31
Total revenue: 2988813000
Gross profit: 475232000
Operating income: 212219000
Net income: 170575000
Capital expenditures: 72132000
Operating cash flow: 309206000
Depreciation & amortization: 65872000
Net tangible assets: 1383814000
Owner earnings: 164315000
Return on net tangible assets (%): 11.874066890492509
Capex to operating income (%): 33.989416593236236
Buffett classification: The Good
Stock price: 28.28
P/E ratio: 22.8094782947677
Shares outstanding: 550314959
Book value: 8038443000
P/B ratio: 1.9360598862889244
Market cap (USD): 15562907040.52
Debt to equity: 0.3554659776775179
Current ratio: 2.4523528130889543
Quick ratio: 1.313514690533935
Effective tax rate (%): 21.80141512245899
Interest coverage ratio: 10.90427499743089
COGS to revenue (%): 84.09964089422792
SG&A to revenue (%): 8.799914882597205
Free cash flow (dilution-adjusted): 231585000
Buyback yield (%): 0
Retained earnings: 7688663000
Inventory turnover: 1.6572522476191984
Receivables turnover: 3.6513460981661496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.757991622205141
FCF margin (%): 7.74839376033228
Rule of 40 score: 7.74839376033228
Financial ratios for HRL — quarterly report dated 2025-04-30
Total revenue: 2898810000
Gross profit: 484433000
Operating income: 233001000
Net income: 180017000
Capital expenditures: 75036000
Operating cash flow: 56440000
Depreciation & amortization: 63963000
Net tangible assets: 1386892000
Owner earnings: 168944000
Return on net tangible assets (%): 12.181482047628798
Capex to operating income (%): 32.20415363024193
Buffett classification: The Good
Stock price: 28.48
P/E ratio: 21.765958259942117
Shares outstanding: 550314959
Book value: 8041941000
P/B ratio: 1.9489038818265394
Market cap (USD): 15672970032.32
Debt to equity: 0.3553801252707524
Current ratio: 2.4720629617132044
Quick ratio: 1.1695971269839356
Effective tax rate (%): 22.017102768461836
Interest coverage ratio: 11.938973150235704
COGS to revenue (%): 83.28855633863552
SG&A to revenue (%): 8.673628143962523
Free cash flow (dilution-adjusted): -29724000
Buyback yield (%): 0
Retained earnings: 7708693000
Inventory turnover: 1.3962094264695932
Receivables turnover: 3.648550679034877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.926560490763133
FCF margin (%): -1.0253862791973258
Revenue growth (%): -3.0113292467611723
Rule of 40 score: -4.036715525958498
Financial ratios for HRL — quarterly report dated 2025-07-31
Total revenue: 3032876000
Gross profit: 487309000
Operating income: 228596000
Net income: 183742000
Capital expenditures: 72185000
Operating cash flow: 156699000
Depreciation & amortization: 64692000
Net tangible assets: 1438563000
Owner earnings: 176249000
Return on net tangible assets (%): 12.251740104534873
Capex to operating income (%): 31.577542914136732
Buffett classification: The Good
Stock price: 27.01
P/E ratio: 27.817820020043644
Shares outstanding: 550314959
Book value: 8093092000
P/B ratio: 1.8366289475752902
Market cap (USD): 14864007042.59
Debt to equity: 0.3530053779198358
Current ratio: 2.4692779281934047
Quick ratio: 1.1152697336590536
Effective tax rate (%): 22.33187041781882
Interest coverage ratio: 11.746364523919635
COGS to revenue (%): 83.93244563905678
SG&A to revenue (%): 8.530286104674243
Free cash flow (dilution-adjusted): 79653000
Buyback yield (%): 0
Retained earnings: 7732618000
Inventory turnover: 1.3972352431032022
Receivables turnover: 3.721790606665628
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8812635300478677
FCF margin (%): 2.6263190450252503
Revenue growth (%): 4.62486330597728
Rule of 40 score: 7.25118235100253
Financial ratios for HRL — annual report dated 2025-10-31
Total revenue: 12106160000
Gross profit: 1891816000
Operating income: 895192000
Net income: 478197000
Capital expenditures: 310770000
Operating cash flow: 845251000
Depreciation & amortization: 263901000
Net tangible assets: 1329786000
Owner earnings: 431328000
Return on net tangible assets (%): 32.43589570051121
Capex to operating income (%): 34.71545768952359
Buffett classification: The Good
Stock price: 21.02
P/E ratio: 24.190073208698507
Shares outstanding: 550314959
Book value: 7915815000
P/B ratio: 1.461330316357823
Market cap (USD): 11567620438.18
Debt to equity: 0.36097660190391007
Current ratio: 2.466443993174951
Quick ratio: 1.2010296959145303
Effective tax rate (%): 27.987682549826737
Interest coverage ratio: 11.471231963915017
COGS to revenue (%): 84.37311253114117
SG&A to revenue (%): 8.232370958255961
Free cash flow (dilution-adjusted): 508747000
Buyback yield (%): 0
Retained earnings: 7516690000
Inventory turnover: 5.845857473248405
Receivables turnover: 13.731985939249299
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.4522804623219
FCF margin (%): 4.202381267057432
Revenue growth (%): 1.5549547568002375
Rule of 40 score: 5.75733602385767
Financial ratios for HRL — quarterly report dated 2025-10-31
Total revenue: 3185661000
Gross profit: 444841000
Operating income: 221375000
Net income: -56137000
Capital expenditures: 91417000
Operating cash flow: 322906000
Depreciation & amortization: 69374000
Net tangible assets: 1329786000
Owner earnings: -78180000
Return on net tangible assets (%): -5.879141455843271
Capex to operating income (%): 41.29508752117448
Buffett classification: The Good
Stock price: 21.02
P/E ratio: 24.190073208698507
Shares outstanding: 550314959
Book value: 7915815000
P/B ratio: 1.461330316357823
Market cap (USD): 11567620438.18
Debt to equity: 0.36097660190391007
Current ratio: 2.466443993174951
Quick ratio: 1.2010296959145303
Interest coverage ratio: 11.294642857142858
COGS to revenue (%): 86.03614760013699
SG&A to revenue (%): 7.014745134526241
Free cash flow (dilution-adjusted): 227233000
Buyback yield (%): 0
Retained earnings: 7516690000
Inventory turnover: 1.5686218400152465
Receivables turnover: 3.613487023070475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8428991628013998
FCF margin (%): 7.132993749177957
Revenue growth (%): 5.037627651113992
Rule of 40 score: 12.17062140029195
Financial ratios for HRL — quarterly report dated 2026-01-31
Total revenue: 3027317000
Gross profit: 469575000
Operating income: 227877000
Net income: 181801000
Capital expenditures: 68988000
Operating cash flow: 349214000
Depreciation & amortization: 67095000
Net tangible assets: 1461863000
Owner earnings: 179908000
Return on net tangible assets (%): 12.306761987956463
Capex to operating income (%): 30.274226885556683
Buffett classification: The Good
Stock price: 24.26
P/E ratio: 27.278327551708852
Shares outstanding: 550314959
Book value: 7953207000
P/B ratio: 1.6786487394757865
Market cap (USD): 13350640905.34
Debt to equity: 0.3592880205431595
Current ratio: 2.661791774326213
Quick ratio: 1.3677003292437764
Effective tax rate (%): 22.42394755710335
Interest coverage ratio: 11.550942822384428
COGS to revenue (%): 84.4887403598632
SG&A to revenue (%): 7.983901256459102
Free cash flow (dilution-adjusted): 273302000
Buyback yield (%): 0
Retained earnings: 7537481000
Inventory turnover: 1.5527147627803803
Receivables turnover: 4.009372765078272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.89211356550695
FCF margin (%): 9.027861964901595
Revenue growth (%): -4.970522601117947
Rule of 40 score: 4.0573393637836475
Financial ratios for IDR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.44
Shares outstanding: 15809859
Market cap (USD): 117625350.96000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDR — annual report dated 2022-12-31
Total revenue: 9580189
Gross profit: 1553921
Operating income: -2483596
Net income: -2535429
Capital expenditures: 2144525
Operating cash flow: -1817090
Depreciation & amortization: 984083
Net tangible assets: 14877238
Owner earnings: -3695871
Return on net tangible assets (%): -24.842453955498996
Buffett classification: The Gruesome
Stock price: 5.7
Shares outstanding: 15809859
Book value: 17713070
P/B ratio: 5.087553783731448
Market cap (USD): 90116196.3
Debt to equity: 0.12700474847104426
Current ratio: 2.06113810326754
Quick ratio: 1.6818768711943564
Interest coverage ratio: -24.15197603858721
COGS to revenue (%): 83.779850272265
SG&A to revenue (%): 16.74919983311394
Free cash flow (dilution-adjusted): -4541216
Buyback yield (%): 0
Retained earnings: -18368384
Inventory turnover: 12.980914197178452
Receivables turnover: 10.505480177602715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.832924927784969
FCF margin (%): -47.40215459214844
Rule of 40 score: -47.40215459214844